|
1
|
Ciani L and Salinas PC: WNTs in the
vertebrate nervous system: From patterning to neuronal
connectivity. Nat Rev Neurosci. 6:351–362. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang Y, Li YP, Paulson C, Shao JZ, Zhang
X, Wu M and Chen W: Wnt and the Wnt signaling pathway in bone
development and disease. Front Biosci (Landmark Ed). 19:379–407.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Regard JB, Zhong Z, Williams BO and Yang
Y: Wnt signaling in bone development and disease: Making stronger
bone with Wnts. Cold Spring Harb Perspect Biol. 4:a0079972012.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Niemann S, Zhao C, Pascu F, Stahl U,
Aulepp U, Niswander L, Weber JL and Müller U: Homozygous WNT3
mutation causes tetra-amelia in a large consanguineous family. Am J
Hum Genet. 74:558–563. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Day TF, Guo X, Garrett-Beal L and Yang Y:
Wnt/beta-catenin signaling in mesenchymal progenitors controls
osteoblast and chondrocyte differentiation during vertebrate
skeletogenesis. Dev Cell. 8:739–750. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rodda SJ and McMahon AP: Distinct roles
for Hedgehog and canonical Wnt signaling in specification,
differentiation and maintenance of osteoblast progenitors.
Development. 133:3231–3244. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Holmen SL, Zylstra CR, Mukherjee A, Sigler
RE, Faugere MC, Bouxsein ML, Deng L, Clemens TL and Williams BO:
Essential role of beta-catenin in postnatal bone acquisition. J
Biol Chem. 280:21162–21168. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
MacDonald BT, Tamai K and He X:
Wnt/beta-catenin signaling: Components, mechanisms, and diseases.
Dev Cell. 17:9–26. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li Z, Xu Z, Duan C, Liu W, Sun J and Han
B: Role of TCF/LEF transcription factors in bone development and
osteogenesis. Int J Med Sci. 15:1415–1422. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Krishnan V, Bryant HU and Macdougald OA:
Regulation of bone mass by Wnt signaling. J Clin Invest.
116:1202–1209. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Komiya Y and Habas R: Wnt signal
transduction pathways. Organogenesis. 4:68–75. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Smolich BD, McMahon JA, McMahon AP and
Papkoff J: Wnt family proteins are secreted and associated with the
cell surface. Mol Biol Cell. 4:1267–1275. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Komekado H, Yamamoto H, Chiba T and
Kikuchi A: Glycosylation and palmitoylation of Wnt-3a are coupled
to produce an active form of Wnt-3a. Genes Cells. 12:521–534. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jeong BC, Kim TS, Kim HS, Lee SH and Choi
Y: Transmembrane protein 64 reciprocally regulates osteoblast and
adipocyte differentiation by modulating Wnt/β-catenin signaling.
Bone. 78:165–173. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lim W, Kim J, Kim S, Karna S, Won J, Jeon
SM, Kim SY, Choi Y, Choi H and Kim O: Modulation of
lipopolysaccharide-induced NF-κB signaling pathway by 635 nm
irradiation via heat shock protein 27 in human gingival fibroblast
cells. Photochem Photobiol. 89:199–207. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Arguello F, Baggs RB and Frantz CN: A
murine model of experimental metastasis to bone and bone marrow.
Cancer Res. 48:6876–6881. 1988.PubMed/NCBI
|
|
17
|
He X, Semenov M, Tamai K and Zeng X: LDL
receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling:
Arrows point the way. Development. 131:1663–1677. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang Y, Huang Y, Zhang M, Zhang X, Tang X
and Kang Y: Bioinformatic analysis of the possible regulative
network of miR-30a/e in Cardiomyocytes 2 Days post myocardial
infarction. Acta Cardiol Sin. 34:175–188. 2018.PubMed/NCBI
|
|
19
|
Chu K, Cheng CJ, Ye X, Lee YC, Zurita AJ,
Chen DT, Yu-Lee LY, Zhang S, Yeh ET, Hu MC, et al: Cadherin-11
promotes the metastasis of prostate cancer cells to bone. Mol
Cancer Res. 6:1259–1267. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Murillo-Garzón V and Kypta R: WNT
signalling in prostate cancer. Nat Rev Urol. 14:683–696. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nandana S, Tripathi M, Duan P, Chu CY,
Mishra R, Liu C, Jin R, Yamashita H, Zayzafoon M, Bhowmick NA, et
al: Bone metastasis of prostate cancer can be therapeutically
targeted at the TBX2-WNT signaling axis. Cancer Res. 77:1331–1344.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kim H, Kim T, Jeong BC, Cho IT, Han D,
Takegahara N, Negishi-Koga T, Takayanagi H, Lee JH, Sul JY, et al:
Tmem64 modulates calcium signaling during RANKL-mediated osteoclast
differentiation. Cell Metab. 17:249–260. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Verras M and Sun Z: Roles and regulation
of Wnt signaling and beta-catenin in prostate cancer. Cancer Lett.
237:22–32. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yu X, Wang Y, DeGraff DJ, Wills ML and
Matusik RJ: Wnt/β-catenin activation promotes prostate tumor
progression in a mouse model. Oncogene. 30:1868–1879. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bryden AA, Hoyland JA, Freemont AJ, Clarke
NW, Schembri Wismayer D and George NJ: E-cadherin and beta-catenin
are down-regulated in prostatic bone metastases. BJU Int.
89:400–403. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang Y, Ye YC, Chen Y, Zhao JL, Gao CC,
Han H, Liu WC and Qin HY: Crosstalk between hepatic tumor cells and
macrophages via Wnt/β-catenin signaling promotes M2-like macrophage
polarization and reinforces tumor malignant behaviors. Cell Death
Dis. 9:7932018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kishida S, Yamamoto H, Ikeda S, Kishida M,
Sakamoto I, Koyama S and Kikuchi A: Axin, a negative regulator of
the wnt signaling pathway, directly interacts with adenomatous
polyposis coli and regulates the stabilization of beta-catenin. J
Biol Chem. 273:10823–10826. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Novellasdemunt L, Antas P and Li VS:
Targeting Wnt signaling in colorectal cancer. A review in the
theme: Cell signaling: Proteins, pathways and mechanisms. Am J
Physiol Cell Physiol. 309:C511–C521. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Powell SM, Zilz N, Beazer-Barclay Y, Bryan
TM, Hamilton SR, Thibodeau SN, Vogelstein B and Kinzler KW: APC
mutations occur early during colorectal tumorigenesis. Nature.
359:235–237. 1992. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Logan CY and Nusse R: The Wnt signaling
pathway in development and disease. Annu Rev Cell Dev Biol.
20:781–810. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lee HJ, Li J, Vickman RE, Li J, Liu R,
Durkes AC, Elzey BD, Yue S, Liu X, Ratliff TL and Cheng JX:
Cholesterol esterification inhibition suppresses prostate cancer
metastasis by impairing the Wnt/β-catenin Pathway. Mol Cancer Res.
16:974–985. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Suva LJ, Washam C, Nicholas RW and Griffin
RJ: Bone metastasis: Mechanisms and therapeutic opportunities. Nat
Rev Endocrinol. 7:208–218. 2011. View Article : Google Scholar : PubMed/NCBI
|
